HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Validation of a rapid test (VWF-LIA) for the quantitative determination of von Willebrand factor antigen in type 1 von Willebrand disease diagnosis within the European multicenter study MCMDM-1VWD.

AbstractBACKGROUND:
Accurate measurement of von Willebrand factor (VWF) is a critical requirement for the diagnosis of von Willebrand disease (VWD).
AIM OF THE STUDY:
To evaluate the diagnostic efficiency of a rapid quantitative test for the measurement of VWF antigen (VWF:Ag) in type 1 VWD.
PATIENTS AND METHODS:
VWF:Ag was measured with an ELISA in a robotic instrument, as a reference method, and with a fully automated latex-immunoassay (LIA) on an ACL 9000 analyser in 1,716 subjects enrolled within the Molecular and Clinical Markers for Diagnosis and Management of Type 1 von Willebrand Disease (MCMDM-1VWD) Study. Among these subjects, 1,049 were healthy controls, 281 healthy family members and 386 affected members from 127 European families with type 1 VWD.
RESULTS:
The assay linearity range was 10-125 IU/dL for LIA (R2=0.99) and 5-133 IU/dL for ELISA (R2=0.99). The inter-assay CV for low VWF levels (approximately 30 IU/dL) was 2% for the LIA test and 8.7 % for ELISA. The sensitivity for detection of type 1 VWD affected members was 86% and the specificity 91% for LIA, 87% and 90% for ELISA. A receiver-operator (ROC) analysis disclosed only a marginal difference between the two tests, LIA having a slightly greater area under the curve (0.94 vs. 0.93, p=0.03).
CONCLUSION:
VWF:Ag LIA compared well to standard ELISA in this large population of patients and controls, showing better CV. However the lower detection limit for the VWF:Ag LIA compared to the VWF:Ag ELISA means that the LIA assay is less good at discriminating between type 3 VWD and moderate type 1 VWD.
AuthorsG Castaman, A Tosetto, A Cappelletti, A Goodeve, A B Federici, J Batlle, D Meyer, J Goudemand, J C J Eikenboom, R Schneppenheim, U Budde, J Ingerslev, S Lethagen, F Hill, I R Peake, F Rodeghiero
JournalThrombosis research (Thromb Res) Vol. 126 Issue 3 Pg. 227-31 (Sep 2010) ISSN: 1879-2472 [Electronic] United States
PMID20650506 (Publication Type: Comparative Study, Journal Article, Multicenter Study, Validation Study)
CopyrightCopyright (c) 2010 Elsevier Ltd. All rights reserved.
Chemical References
  • Biomarkers
  • von Willebrand Factor
Topics
  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Automation, Laboratory
  • Biomarkers (blood)
  • Case-Control Studies
  • Child
  • Child, Preschool
  • Enzyme-Linked Immunosorbent Assay (standards)
  • Europe
  • Humans
  • Latex Fixation Tests (standards)
  • Middle Aged
  • Observer Variation
  • Predictive Value of Tests
  • ROC Curve
  • Reference Standards
  • Reproducibility of Results
  • Robotics
  • Sensitivity and Specificity
  • Young Adult
  • von Willebrand Disease, Type 1 (blood, diagnosis)
  • von Willebrand Factor (analysis)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: